Pharmacokinetic Profile of Armodafinil in Healthy Subjects: Pooled Analysis of Data from Three Randomized Studies

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 87-100

Adis International

Access to resources Recommend Favorite

An Extended Terminal Half-Life for Darbepoetin Alfa: Results from a Single-Dose Pharmacokinetic Study in Patients with Chronic Kidney Disease not Receiving Dialysis

By Padhi Desmond   Ni Liyun   Cooke Blaire   Marino Rafael   Jang Graham  

Clinical Pharmacokinetics, Vol. 45, Iss. 5, 2006-01 ,pp. : 503-510

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in Determining the Terminal Elimination Half-Lives of Bisphosphonates

By Kenneth C. Lasseter  

Clinical Drug Investigation, Vol. 25, Iss. 2, 2005-01 ,pp. : 107-114

Adis International

Access to resources Recommend Favorite

Single-Dose Clinical Pharmacokinetic Studies of Gefitinib

By Swaisland Helen C.  

Clinical Pharmacokinetics, Vol. 44, Iss. 11, 2005-01 ,pp. : 1165-1177

Adis International

Access to resources Recommend Favorite

Comparison of Steady-State Plasma Concentrations of Armodafinil and Modafinil Late in the Day Following Morning Administration: Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies in Healthy Male Subjects

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 601-612

Adis International

Access to resources Recommend Favorite